ALKS
Alkermes Plc
Position levels
Currenttoday
USD 48.99
Buy <=wait / entry
USD 36.67
Trim >=take some off
USD 50.00
Thesis breakThe thesis would be invalidated by a combination of materially weaker-than-guide...
-
Scenario-weighted conviction
| Probability | Score | Contribution | |
|---|---|---|---|
| Bull case | 19% | 100 / 100 | 19.0 |
| Base case | 50% | 62 / 100 | 31.0 |
| Bear case | 31% | 10 / 100 | 3.1 |
| Weighted conviction | 53 / 100 - OPPORTUNISTIC BUY | ||
Top risks
- Completion of Avadel Pharmaceuticals acquisition expected to be accretive in 2026
- Q2 2026 financial results reported with 2026 financial expectations provided
- Strong Buy consensus from 13 analysts